Tandem Diabetes Care, Inc. Revenue, Net (Deprecated 2018-01-31)
Tandem Diabetes Care, Inc. (TNDM) reported Revenue, Net (Deprecated 2018-01-31) of $27.28 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-04-26.
Discontinued › Income Statement
us-gaap:SalesRevenueNet · last filed 2018-04-26
- Tandem Diabetes Care, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $27.28M, a 43.74% increase year-over-year.
- Tandem Diabetes Care, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $40.29M, a 39.37% increase year-over-year.
- Tandem Diabetes Care, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $27.00M, a 119.66% increase year-over-year.
- Tandem Diabetes Care, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $21.33M, a 7.21% decline year-over-year.
- Tandem Diabetes Care, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2017 was $107.60M, a 27.72% increase from fiscal 2016.
- Tandem Diabetes Care, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2016 was $84.25M, a 15.65% increase from fiscal 2015.
- Tandem Diabetes Care, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2015 was $72.85M, a 46.51% increase from fiscal 2014.
- Tandem Diabetes Care, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2014 was $49.72M, a 71.41% increase from fiscal 2013.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 3 month as first filed | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 6 month as first filed | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 9 month as first filed | Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|---|---|
| 2018-03-31 | $27.28M 10-Q · filed 2018-04-26 | $67.57M derived: sum of 2 quarters · filed 2018-04-26 | $94.57M derived: sum of 3 quarters · filed 2018-04-26 | $115.90M derived: sum of 4 quarters · filed 2018-04-26 | |||
| 2017-12-31 | $40.29M 10-K · filed 2018-03-01 | $67.30M derived: sum of 2 quarters · filed 2018-03-01 | $88.62M derived: sum of 3 quarters · filed 2018-03-01 | $107.60M 10-K · filed 2018-03-01 | |||
| 2017-09-30 | $27.00M 10-K · filed 2018-03-01 | $48.33M derived: sum of 2 quarters · filed 2018-03-01 | $67.31M 10-Q · filed 2017-10-26 | $96.22M derived: sum of 4 quarters · filed 2018-04-26 | |||
| 2017-06-30 | $21.33M 10-K · filed 2018-03-01 | $40.30M 10-Q · filed 2017-07-27 | $69.22M derived: sum of 3 quarters · filed 2018-04-26 | $81.51M derived: sum of 4 quarters · filed 2018-04-26 | |||
| 2017-03-31 | $18.98M 10-Q · filed 2018-04-26 | $47.89M derived: sum of 2 quarters · filed 2018-04-26 | $60.18M derived: sum of 3 quarters · filed 2018-04-26 | $83.17M derived: sum of 4 quarters · filed 2018-04-26 | |||
| 2016-12-31 | $28.91M 10-K · filed 2018-03-01 | $41.20M derived: sum of 2 quarters · filed 2018-03-01 | $64.19M derived: sum of 3 quarters · filed 2018-03-01 | $84.25M 10-K · filed 2018-03-01 | |||
| 2016-09-30 | $12.29M 10-K · filed 2018-03-01 | $35.28M derived: sum of 2 quarters · filed 2018-03-01 | $55.34M 10-Q · filed 2017-10-26 | $84.46M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-06-30 | $22.98M 10-K · filed 2018-03-01 | $43.04M 10-Q · filed 2017-07-27 | $72.16M derived: sum of 3 quarters · filed 2018-03-01 | $87.88M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-03-31 | $20.06M 10-K · filed 2018-03-01 | $49.18M derived: sum of 2 quarters · filed 2018-03-01 | $64.89M derived: sum of 3 quarters · filed 2018-03-01 | $80.60M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | $29.12M 10-K · filed 2017-03-08 | $44.84M derived: sum of 2 quarters · filed 2017-03-08 | $60.54M derived: sum of 3 quarters · filed 2017-03-08 | $72.85M 10-K · filed 2018-03-01 | |||
| 2015-09-30 | $15.72M 10-K · filed 2017-03-08 | $31.42M derived: sum of 2 quarters · filed 2017-03-08 | $43.73M 10-Q · filed 2016-11-01 | $61.62M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2015-06-30 | $15.71M 10-K · filed 2017-03-08 | $28.01M 10-Q · filed 2016-07-28 | $45.90M derived: sum of 3 quarters · filed 2017-03-08 | $59.42M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2015-03-31 | $12.31M 10-K · filed 2017-03-08 | $30.20M derived: sum of 2 quarters · filed 2017-03-08 | $43.71M derived: sum of 3 quarters · filed 2017-03-08 | $53.96M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2014-12-31 | $17.89M 10-K · filed 2017-03-08 | $31.40M derived: sum of 2 quarters · filed 2017-03-08 | $41.66M derived: sum of 3 quarters · filed 2017-03-08 | $49.72M 10-K · filed 2017-03-08 | |||
| 2014-09-30 | $13.51M 10-K · filed 2017-03-08 | $13.51M 10-Q · filed 2014-11-06 | $23.77M derived: sum of 2 quarters · filed 2017-03-08 | $31.83M 10-Q · filed 2015-10-29 | $31.83M 10-Q · filed 2014-11-06 | $42.08M derived: sum of 4 quarters · filed 2017-03-08 | |
| 2014-06-30 | $10.25M 10-Q · filed 2014-07-31 | $18.32M 10-Q · filed 2015-07-30 | $18.32M 10-Q · filed 2014-07-31 | $28.57M derived: sum of 3 quarters · filed 2017-03-08 | $36.34M derived: sum of 4 quarters · filed 2017-03-08 | ||
| 2014-03-31 | $8.07M 10-K · filed 2017-03-08 | $8.07M 10-Q · filed 2014-05-06 | $18.31M derived: sum of 2 quarters · filed 2017-03-08 | $26.09M derived: sum of 3 quarters · filed 2017-03-08 | $31.61M derived: sum of 4 quarters · filed 2017-03-08 | ||
| 2013-12-31 | $10.24M 10-K · filed 2015-02-24 | $18.02M derived: sum of 2 quarters · filed 2015-02-24 | $23.55M derived: sum of 3 quarters · filed 2015-02-24 | $29.01M 10-K · filed 2016-02-24 | |||
| 2013-09-30 | $7.78M 10-K · filed 2015-02-24 | $7.78M 10-Q · filed 2014-11-06 | $13.30M derived: sum of 2 quarters · filed 2015-02-24 | $18.76M 10-Q · filed 2014-11-06 | |||
| 2013-06-30 | $5.53M 10-K · filed 2015-02-24 | $5.53M 10-Q · filed 2014-07-31 | $10.99M 10-Q · filed 2014-07-31 | ||||
| 2013-03-31 | $5.46M 10-K · filed 2015-02-24 | $5.46M 10-Q · filed 2014-05-06 | |||||
| 2012-12-31 | $2.48M 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |